Rein Therapeutics, Inc. Common Stock (RNTX) is a publicly traded Healthcare sector company. As of July 21, 2026, RNTX trades at $0.85 with a market cap of $73.74M and a P/E ratio of -0.44. RNTX moved -1.65% today. Year to date, RNTX is -21.12%; over the trailing twelve months it is -40.56%. Its 52-week range spans $0.83 to $3.50. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces RNTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rein Therapeutics, Inc. Common Stock (RNTX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. RNTX moved -1.65% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $0.85 |
| Market Cap | $73.74M |
| P/E Ratio | -0.44 |
| EPS | $-1.96 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.50 |
| 52-Week Low | $0.83 |
| Volume | 562.87K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-49.87M |
| Gross Margin | 0.00% |
1 analysts cover RNTX: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.